Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) ...

Lusvertikimab selectively inhibits IL-7 but not the thymic stromal lymphopoietin (TSLP) axis, Bourreille told attendees. A ...

Lang and co-authors evaluated 25 of 222 verified cases reported to Public Health New Brunswick. All patients had a ...

Pharmaceutical giant Eli Lilly will invest $250 million in an eight-year research partnership with Purdue University. Why it ...

Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time. Let's consider four ...

Eli Lilly and Purdue University announced a $250 million in what the two institutions say is the largest industry-academic partnership in the country.

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...

Eli Lilly and Co. and Purdue University announce a $250 million investment to continue to accelerate pharmaceutical innovation and boost Indiana's economy.

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

In an announcement made Friday, Lilly said they will invest up to $250 million through the “Lilly-Purdue 360” initiative over ...

This partnership, which officials said has the potential to be the largest ever U.S. industry-academic agreement of its kind, ...